speb/financial-data huggingface dataset:
CTAS balance_sheet (annual, 2023-05-31) — Current Liabilities: 1230062000.00
CTAS balance_sheet (annual, 2023-05-31) — Current Provisions: 182046000.00
CTAS cash_flow (annual, 2023-05-31) — Deferred Income Tax: 23233000.00
CTAS cash_flow (annual, 2023-05-31) — Deferred Tax: 23233000.00
CTAS cash_flow (annual, 2023-05-31) — Depreciation: 267223000.00
CTAS cash_flow (annual, 2023-05-31) — Depreciation Amortization Depletion: 419344000.00
CTAS cash_flow (annual, 2023-05-31) — Depreciation And Amortization: 419344000.00
CTAS income_statement (annual, 2023-05-31) — Diluted Average Shares: 413508000.00
CTAS income_statement (annual, 2023-05-31) — Diluted EPS: 3.25
CTAS income_statement (annual, 2023-05-31) — Diluted NI Availto Com Stockholders: 1342547000.00
CTAS balance_sheet (annual, 2023-05-31) — Dividends Payable: 117565000.00
CTAS income_statement (annual, 2023-05-31) — EBIT: 1804380000.00
CTAS income_statement (annual, 2023-05-31) — EBITDA: 2223724000.00
CTAS cash_flow (annual, 2023-05-31) — Earnings Losses From Equity Investments: 0.00
CTAS cash_flow (annual, 2023-05-31) — Effect Of Exchange Rate Changes: -4186000.00
CTAS cash_flow (annual, 2023-05-31) — End Cash Position: 124149000.00
CTAS cash_flow (annual, 2023-05-31) — Financing Cash Flow: -1166752000.00
CTAS balance_sheet (annual, 2023-05-31) — Finished Goods: 1434260000.00
CTAS cash_flow (annual, 2023-05-31) — Free Cash Flow: 1255119000.00
CTAS cash_flow (annual, 2023-05-31) — Gain Loss On Sale Of PPE: 0.00
CTAS balance_sheet (annual, 2023-05-31) — Gains Losses Not Affecting Retained Earnings: 77778000.00
CTAS balance_sheet (annual, 2023-05-31) — Goodwill: 3056201000.00
CTAS balance_sheet (annual, 2023-05-31) — Goodwill And Other Intangible Assets: 3402775000.00
CTAS balance_sheet (annual, 2023-05-31) — Gross Accounts Receivable: 1167919000.00
CTAS balance_sheet (annual, 2023-05-31) — Gross PPE: 3937209000.00
CTAS income_statement (annual, 2023-05-31) — Gross Profit: 4173368000.00
CTAS balance_sheet (annual, 2023-05-31) — Income Tax Payable: 12470000.00
CTAS income_statement (annual, 2023-05-31) — Interest Expense: 111232000.00
CTAS income_statement (annual, 2023-05-31) — Interest Expense Non Operating: 111232000.00
CTAS income_statement (annual, 2023-05-31) — Interest Income: 1716000.00
CTAS income_statement (annual, 2023-05-31) — Interest Income Non Operating: 1716000.00
CTAS balance_sheet (annual, 2023-05-31) — Interest Payable: 15151000.00
CTAS balance_sheet (annual, 2023-05-31) — Inventory: 1518522000.00
CTAS balance_sheet (annual, 2023-05-31) — Invested Capital: 6350391000.00
CTAS cash_flow (annual, 2023-05-31) — Investing Cash Flow: -381612000.00
CTAS balance_sheet (annual, 2023-05-31) — Investments And Advances: 247191000.00
CTAS cash_flow (annual, 2023-05-31) — Issuance Of Debt: 0.00
CTAS balance_sheet (annual, 2023-05-31) — Land And Improvements: 190707000.00
CTAS balance_sheet (annual, 2023-05-31) — Leases: 44897000.00
CTAS balance_sheet (annual, 2023-05-31) — Long Term Capital Lease Obligation: 138278000.00
CTAS balance_sheet (annual, 2023-05-31) — Long Term Debt: 2486405000.00
CTAS balance_sheet (annual, 2023-05-31) — Long Term Debt And Capital Lease Obligation: 2624683000.00
CTAS cash_flow (annual, 2023-05-31) — Long Term Debt Issuance: 0.00
CTAS cash_flow (annual, 2023-05-31) — Long Term Debt Payments: -50000000.00
CTAS cash_flow (annual, 2023-05-31) — Net Business Purchase And Sale: -46357000.00
CTAS cash_flow (annual, 2023-05-31) — Net Common Stock Issuance: -398865000.00
CTAS balance_sheet (annual, 2023-05-31) — Net Debt: 2362256000.00
CTAS income_statement (annual, 2023-05-31) — Net Income: 1348010000.00
CTAS income_statement (annual, 2023-05-31) — Net Income Common Stockholders: 1342547000.00
CTAS income_statement (annual, 2023-05-31) — Net Income Continuous Operations: 1348010000.00
CTAS income_statement (annual, 2023-05-31) — Net Income From Continuing And Discontinued Operation: 1348010000.00
CTAS income_statement (annual, 2023-05-31) — Net Income From Continuing Operation Net Minority Interest: 1348010000.00
CTAS cash_flow (annual, 2023-05-31) — Net Income From Continuing Operations: 1348010000.00
CTAS income_statement (annual, 2023-05-31) — Net Income Including Noncontrolling Interests: 1348010000.00
CTAS income_statement (annual, 2023-05-31) — Net Interest Income: -109516000.00
CTAS cash_flow (annual, 2023-05-31) — Net Investment Purchase And Sale: -4566000.00
CTAS cash_flow (annual, 2023-05-31) — Net Issuance Payments Of Debt: -311200000.00
CTAS cash_flow (annual, 2023-05-31) — Net Long Term Debt Issuance: -50000000.00
CTAS income_statement (annual, 2023-05-31) — Net Non Operating Interest Income Expense: -109516000.00
CTAS cash_flow (annual, 2023-05-31) — Net Other Financing Charges: -9791000.00
CTAS cash_flow (annual, 2023-05-31) — Net Other Investing Changes: 420000.00
CTAS balance_sheet (annual, 2023-05-31) — Net PPE: 1574940000.00
CTAS cash_flow (annual, 2023-05-31) — Net PPE Purchase And Sale: 0.00
CTAS cash_flow (annual, 2023-05-31) — Net Short Term Debt Issuance: -261200000.00
CTAS balance_sheet (annual, 2023-05-31) — Net Tangible Assets: 461211000.00
CTAS balance_sheet (annual, 2023-05-31) — Non Current Accrued Expenses: 329269000.00
CTAS balance_sheet (annual, 2023-05-31) — Non Current Deferred Assets: 252025000.00
CTAS balance_sheet (annual, 2023-05-31) — Non Current Deferred Liabilities: 498356000.00
CTAS balance_sheet (annual, 2023-05-31) — Non Current Deferred Taxes Liabilities: 498356000.00
CTAS income_statement (annual, 2023-05-31) — Normalized EBITDA: 2223724000.00
CTAS income_statement (annual, 2023-05-31) — Normalized Income: 1348010000.00
CTAS cash_flow (annual, 2023-05-31) — Operating Cash Flow: 1586228000.00
CTAS income_statement (annual, 2023-05-31) — Operating Income: 1802664000.00
CTAS income_statement (annual, 2023-05-31) — Operating Revenue: 6897130000.00
CTAS balance_sheet (annual, 2023-05-31) — Ordinary Shares Number: 406928592.00
CTAS balance_sheet (annual, 2023-05-31) — Other Current Assets: 142795000.00
CTAS balance_sheet (annual, 2023-05-31) — Other Equity Adjustments: 77778000.00
CTAS balance_sheet (annual, 2023-05-31) — Other Intangible Assets: 346574000.00
CTAS balance_sheet (annual, 2023-05-31) — Other Non Current Assets: 130966000.00
CTAS balance_sheet (annual, 2023-05-31) — Other Properties: 2878192000.00
CTAS income_statement (annual, 2023-05-31) — Otherunder Preferred Stock Dividend: 5463000.00
CTAS balance_sheet (annual, 2023-05-31) — Payables: 432327000.00
CTAS balance_sheet (annual, 2023-05-31) — Payables And Accrued Expenses: 598125000.00
CTAS balance_sheet (annual, 2023-05-31) — Pensionand Other Post Retirement Benefit Plans Current: 406181000.00
CTAS balance_sheet (annual, 2023-05-31) — Preferred Stock: 0.00
CTAS income_statement (annual, 2023-05-31) — Pretax Income: 1693148000.00
CTAS cash_flow (annual, 2023-05-31) — Proceeds From Stock Option Exercised: 3021000.00
CTAS balance_sheet (annual, 2023-05-31) — Properties: 0.00
CTAS cash_flow (annual, 2023-05-31) — Purchase Of Business: -46357000.00
CTAS cash_flow (annual, 2023-05-31) — Purchase Of Investment: -4566000.00
CTAS balance_sheet (annual, 2023-05-31) — Raw Materials: 27878000.00
CTAS balance_sheet (annual, 2023-05-31) — Receivables: 1152993000.00
CTAS income_statement (annual, 2023-05-31) — Reconciled Cost Of Revenue: 4642401000.00
CTAS income_statement (annual, 2023-05-31) — Reconciled Depreciation: 419344000.00
CTAS cash_flow (annual, 2023-05-31) — Repayment Of Debt: -50000000.00
CTAS cash_flow (annual, 2023-05-31) — Repurchase Of Capital Stock: -398865000.00
CTAS balance_sheet (annual, 2023-05-31) — Retained Earnings: 9597315000.00
CTAS cash_flow (annual, 2023-05-31) — Sale Of PPE: 0.00
CTAS income_statement (annual, 2023-05-31) — Selling General And Administration: 2370704000.00
CTAS balance_sheet (annual, 2023-05-31) — Share Issued: 768795752.00
CTAS cash_flow (annual, 2023-05-31) — Stock Based Compensation: 103621000.00
CTAS balance_sheet (annual, 2023-05-31) — Stockholders Equity: 3863986000.00
CTAS balance_sheet (annual, 2023-05-31) — Tangible Book Value: 461211000.00
CTAS income_statement (annual, 2023-05-31) — Tax Effect Of Unusual Items: 0.00
CTAS income_statement (annual, 2023-05-31) — Tax Provision: 345138000.00
CTAS income_statement (annual, 2023-05-31) — Tax Rate For Calcs: 0.20
CTAS balance_sheet (annual, 2023-05-31) — Taxes Receivable: 0.00
CTAS balance_sheet (annual, 2023-05-31) — Total Assets: 8546356000.00
CTAS balance_sheet (annual, 2023-05-31) — Total Capitalization: 6350391000.00
CTAS balance_sheet (annual, 2023-05-31) — Total Debt: 2668393000.00
CTAS balance_sheet (annual, 2023-05-31) — Total Equity Gross Minority Interest: 3863986000.00
CTAS income_statement (annual, 2023-05-31) — Total Expenses: 7013105000.00
CTAS balance_sheet (annual, 2023-05-31) — Total Liabilities Net Minority Interest: 4682370000.00
CTAS balance_sheet (annual, 2023-05-31) — Total Non Current Assets: 5607897000.00
CTAS balance_sheet (annual, 2023-05-31) — Total Non Current Liabilities Net Minority Interest: 3452308000.00
CTAS income_statement (annual, 2023-05-31) — Total Operating Income As Reported: 1802664000.00
CTAS balance_sheet (annual, 2023-05-31) — Total Tax Payable: 12470000.00
CTAS balance_sheet (annual, 2023-05-31) — Treasury Shares Number: 361867160.00
CTAS balance_sheet (annual, 2023-05-31) — Treasury Stock: 7842649000.00
CTAS balance_sheet (annual, 2023-05-31) — Work In Process: 56384000.00
CTAS balance_sheet (annual, 2023-05-31) — Working Capital: 1708397000.00
CTAS income_statement (annual, 2024-05-31) — +Operating Expense: 2617783000.00
CTAS income_statement (annual, 2024-05-31) — +Total Revenue: 9596615000.00
CTAS balance_sheet (annual, 2024-05-31) — Accounts Payable: 339166000.00
CTAS balance_sheet (annual, 2024-05-31) — Accounts Receivable: 1244182000.00
CTAS balance_sheet (annual, 2024-05-31) — Accumulated Depreciation: -2582076000.00
CTAS balance_sheet (annual, 2024-05-31) — Allowance For Doubtful Accounts Receivable: -17914000.00
CTAS cash_flow (annual, 2024-05-31) — Amortization Cash Flow: 176004000.00
CTAS cash_flow (annual, 2024-05-31) — Amortization Of Intangibles: 176004000.00
CTAS income_statement (annual, 2024-05-31) — Basic Average Shares: 406612000.00
CTAS income_statement (annual, 2024-05-31) — Basic EPS: 3.85
CTAS cash_flow (annual, 2024-05-31) — Beginning Cash Position: 124149000.00
CTAS balance_sheet (annual, 2024-05-31) — Buildings And Improvements: 744617000.00
CTAS cash_flow (annual, 2024-05-31) — Capital Expenditure: -409469000.00
CTAS cash_flow (annual, 2024-05-31) — Capital Expenditure Reported: -409469000.00
CTAS balance_sheet (annual, 2024-05-31) — Capital Lease Obligations: 192551000.00
CTAS balance_sheet (annual, 2024-05-31) — Capital Stock: 2305301000.00
CTAS balance_sheet (annual, 2024-05-31) — Cash And Cash Equivalents: 342015000.00
CTAS balance_sheet (annual, 2024-05-31) — Cash Cash Equivalents And Short Term Investments: 342015000.00
CTAS cash_flow (annual, 2024-05-31) — Cash Dividends Paid: -530909000.00
CTAS cash_flow (annual, 2024-05-31) — Cash Flow From Continuing Financing Activities: -1247506000.00
CTAS cash_flow (annual, 2024-05-31) — Cash Flow From Continuing Investing Activities: -603334000.00
CTAS cash_flow (annual, 2024-05-31) — Cash Flow From Continuing Operating Activities: 2068500000.00
CTAS cash_flow (annual, 2024-05-31) — Change In Account Payable: 36896000.00
CTAS cash_flow (annual, 2024-05-31) — Change In Accrued Expense: 70737000.00
CTAS cash_flow (annual, 2024-05-31) — Change In Income Tax Payable: 6220000.00
CTAS cash_flow (annual, 2024-05-31) — Change In Inventory: 95766000.00
CTAS cash_flow (annual, 2024-05-31) — Change In Other Current Assets: -22815000.00
CTAS cash_flow (annual, 2024-05-31) — Change In Payable: 43116000.00
CTAS cash_flow (annual, 2024-05-31) — Change In Payables And Accrued Expense: 113853000.00
CTAS cash_flow (annual, 2024-05-31) — Change In Prepaid Assets: -143441000.00
CTAS cash_flow (annual, 2024-05-31) — Change In Receivables: -91399000.00
CTAS cash_flow (annual, 2024-05-31) — Change In Tax Payable: 6220000.00
CTAS cash_flow (annual, 2024-05-31) — Change In Working Capital: -48036000.00
CTAS cash_flow (annual, 2024-05-31) — Changes In Account Receivables: -91399000.00
CTAS cash_flow (annual, 2024-05-31) — Changes In Cash: 217660000.00
CTAS balance_sheet (annual, 2024-05-31) — Common Stock: 2305301000.00
CTAS cash_flow (annual, 2024-05-31) — Common Stock Dividend Paid: -530909000.00
CTAS balance_sheet (annual, 2024-05-31) — Common Stock Equity: 4316372000.00
CTAS cash_flow (annual, 2024-05-31) — Common Stock Payments: -700033000.00
CTAS balance_sheet (annual, 2024-05-31) — Construction In Progress: 166616000.00
CTAS income_statement (annual, 2024-05-31) — Cost Of Revenue: 4910199000.00
CTAS balance_sheet (annual, 2024-05-31) — Current Accrued Expenses: 213549000.00
CTAS balance_sheet (annual, 2024-05-31) — Current Assets: 3185207000.00
CTAS balance_sheet (annual, 2024-05-31) — Current Capital Lease Obligation: 45727000.00
CTAS balance_sheet (annual, 2024-05-31) — Current Debt: 449595000.00
CTAS balance_sheet (annual, 2024-05-31) — Current Debt And Capital Lease Obligation: 495322000.00
CTAS balance_sheet (annual, 2024-05-31) — Current Liabilities: 1828519000.00
CTAS balance_sheet (annual, 2024-05-31) — Current Provisions: 221758000.00
CTAS cash_flow (annual, 2024-05-31) — Deferred Income Tax: -28912000.00
CTAS cash_flow (annual, 2024-05-31) — Deferred Tax: -28912000.00
CTAS cash_flow (annual, 2024-05-31) — Depreciation: 280866000.00
CTAS cash_flow (annual, 2024-05-31) — Depreciation Amortization Depletion: 456870000.00
CTAS cash_flow (annual, 2024-05-31) — Depreciation And Amortization: 456870000.00
CTAS income_statement (annual, 2024-05-31) — Diluted Average Shares: 413468000.00
CTAS income_statement (annual, 2024-05-31) — Diluted EPS: 3.79
CTAS income_statement (annual, 2024-05-31) — Diluted NI Availto Com Stockholders: 1565664000.00
CTAS balance_sheet (annual, 2024-05-31) — Dividends Payable: 137609000.00
CTAS income_statement (annual, 2024-05-31) — EBIT: 2074375000.00
CTAS income_statement (annual, 2024-05-31) — EBITDA: 2531245000.00
CTAS cash_flow (annual, 2024-05-31) — Earnings Losses From Equity Investments: 0.00
CTAS cash_flow (annual, 2024-05-31) — Effect Of Exchange Rate Changes: 206000.00
CTAS cash_flow (annual, 2024-05-31) — End Cash Position: 342015000.00
CTAS cash_flow (annual, 2024-05-31) — Financing Cash Flow: -1247506000.00
CTAS balance_sheet (annual, 2024-05-31) — Finished Goods: 1385223000.00
CTAS cash_flow (annual, 2024-05-31) — Free Cash Flow: 1659031000.00
CTAS cash_flow (annual, 2024-05-31) — Gain Loss On Sale Of PPE: 0.00
CTAS balance_sheet (annual, 2024-05-31) — Gains Losses Not Affecting Retained Earnings: 91201000.00
CTAS balance_sheet (annual, 2024-05-31) — Goodwill: 3212424000.00
CTAS balance_sheet (annual, 2024-05-31) — Goodwill And Other Intangible Assets: 3534326000.00
CTAS balance_sheet (annual, 2024-05-31) — Gross Accounts Receivable: 1262096000.00
CTAS balance_sheet (annual, 2024-05-31) — Gross PPE: 4304197000.00
CTAS income_statement (annual, 2024-05-31) — Gross Profit: 4686416000.00
CTAS balance_sheet (annual, 2024-05-31) — Income Tax Payable: 18618000.00
CTAS income_statement (annual, 2024-05-31) — Interest Expense: 100740000.00
CTAS income_statement (annual, 2024-05-31) — Interest Expense Non Operating: 100740000.00
CTAS income_statement (annual, 2024-05-31) — Interest Income: 5742000.00
CTAS income_statement (annual, 2024-05-31) — Interest Income Non Operating: 5742000.00
CTAS balance_sheet (annual, 2024-05-31) — Interest Payable: 15050000.00
CTAS balance_sheet (annual, 2024-05-31) — Inventory: 1450345000.00
CTAS balance_sheet (annual, 2024-05-31) — Invested Capital: 6791901000.00
CTAS cash_flow (annual, 2024-05-31) — Investing Cash Flow: -603334000.00
CTAS balance_sheet (annual, 2024-05-31) — Investments And Advances: 302212000.00
CTAS cash_flow (annual, 2024-05-31) — Issuance Of Debt: 0.00
CTAS balance_sheet (annual, 2024-05-31) — Land And Improvements: 194661000.00
CTAS balance_sheet (annual, 2024-05-31) — Leases: 46490000.00
CTAS balance_sheet (annual, 2024-05-31) — Long Term Capital Lease Obligation: 146824000.00
CTAS balance_sheet (annual, 2024-05-31) — Long Term Debt: 2025934000.00
CTAS balance_sheet (annual, 2024-05-31) — Long Term Debt And Capital Lease Obligation: 2172758000.00
CTAS cash_flow (annual, 2024-05-31) — Long Term Debt Issuance: 0.00
CTAS cash_flow (annual, 2024-05-31) — Long Term Debt Payments: -13450000.00
CTAS cash_flow (annual, 2024-05-31) — Net Business Purchase And Sale: -186837000.00
CTAS cash_flow (annual, 2024-05-31) — Net Common Stock Issuance: -700033000.00
CTAS balance_sheet (annual, 2024-05-31) — Net Debt: 2133514000.00
CTAS income_statement (annual, 2024-05-31) — Net Income: 1571592000.00
CTAS income_statement (annual, 2024-05-31) — Net Income Common Stockholders: 1565664000.00
CTAS income_statement (annual, 2024-05-31) — Net Income Continuous Operations: 1571592000.00
CTAS income_statement (annual, 2024-05-31) — Net Income From Continuing And Discontinued Operation: 1571592000.00
CTAS income_statement (annual, 2024-05-31) — Net Income From Continuing Operation Net Minority Interest: 1571592000.00
CTAS cash_flow (annual, 2024-05-31) — Net Income From Continuing Operations: 1571592000.00
CTAS income_statement (annual, 2024-05-31) — Net Income Including Noncontrolling Interests: 1571592000.00
CTAS income_statement (annual, 2024-05-31) — Net Interest Income: -94998000.00
CTAS cash_flow (annual, 2024-05-31) — Net Investment Purchase And Sale: -7546000.00
CTAS cash_flow (annual, 2024-05-31) — Net Issuance Payments Of Debt: -13450000.00
CTAS cash_flow (annual, 2024-05-31) — Net Long Term Debt Issuance: -13450000.00
CTAS income_statement (annual, 2024-05-31) — Net Non Operating Interest Income Expense: -94998000.00
CTAS cash_flow (annual, 2024-05-31) — Net Other Financing Charges: -4484000.00
CTAS cash_flow (annual, 2024-05-31) — Net Other Investing Changes: 518000.00
CTAS balance_sheet (annual, 2024-05-31) — Net PPE: 1722121000.00
CTAS cash_flow (annual, 2024-05-31) — Net PPE Purchase And Sale: 0.00
CTAS cash_flow (annual, 2024-05-31) — Net Short Term Debt Issuance: 0.00
CTAS balance_sheet (annual, 2024-05-31) — Net Tangible Assets: 782046000.00
CTAS balance_sheet (annual, 2024-05-31) — Non Current Accrued Expenses: 375656000.00
CTAS balance_sheet (annual, 2024-05-31) — Non Current Deferred Assets: 262494000.00
CTAS balance_sheet (annual, 2024-05-31) — Non Current Deferred Liabilities: 475512000.00
CTAS balance_sheet (annual, 2024-05-31) — Non Current Deferred Taxes Liabilities: 475512000.00
CTAS income_statement (annual, 2024-05-31) — Normalized EBITDA: 2531245000.00
CTAS income_statement (annual, 2024-05-31) — Normalized Income: 1571592000.00
CTAS cash_flow (annual, 2024-05-31) — Operating Cash Flow: 2068500000.00
CTAS income_statement (annual, 2024-05-31) — Operating Income: 2068633000.00
CTAS income_statement (annual, 2024-05-31) — Operating Revenue: 7465199000.00
CTAS balance_sheet (annual, 2024-05-31) — Ordinary Shares Number: 405007976.00
CTAS balance_sheet (annual, 2024-05-31) — Other Current Assets: 148665000.00
CTAS balance_sheet (annual, 2024-05-31) — Other Current Borrowings: 449595000.00
CTAS balance_sheet (annual, 2024-05-31) — Other Equity Adjustments: 91201000.00
CTAS balance_sheet (annual, 2024-05-31) — Other Intangible Assets: 321902000.00
CTAS balance_sheet (annual, 2024-05-31) — Other Non Current Assets: 162457000.00
CTAS balance_sheet (annual, 2024-05-31) — Other Properties: 3151813000.00
CTAS income_statement (annual, 2024-05-31) — Otherunder Preferred Stock Dividend: 5928000.00
CTAS balance_sheet (annual, 2024-05-31) — Payables: 495393000.00
CTAS balance_sheet (annual, 2024-05-31) — Payables And Accrued Expenses: 708942000.00
CTAS balance_sheet (annual, 2024-05-31) — Pensionand Other Post Retirement Benefit Plans Current: 402497000.00
CTAS balance_sheet (annual, 2024-05-31) — Preferred Stock: 0.00
CTAS income_statement (annual, 2024-05-31) — Pretax Income: 1973635000.00
CTAS cash_flow (annual, 2024-05-31) — Proceeds From Stock Option Exercised: 1370000.00
CTAS balance_sheet (annual, 2024-05-31) — Properties: 0.00
CTAS cash_flow (annual, 2024-05-31) — Purchase Of Business: -186837000.00
CTAS cash_flow (annual, 2024-05-31) — Purchase Of Investment: -7546000.00
CTAS balance_sheet (annual, 2024-05-31) — Raw Materials: 16664000.00
CTAS balance_sheet (annual, 2024-05-31) — Receivables: 1244182000.00
CTAS income_statement (annual, 2024-05-31) — Reconciled Cost Of Revenue: 4910199000.00
CTAS income_statement (annual, 2024-05-31) — Reconciled Depreciation: 456870000.00
CTAS cash_flow (annual, 2024-05-31) — Repayment Of Debt: -13450000.00
CTAS cash_flow (annual, 2024-05-31) — Repurchase Of Capital Stock: -700033000.00
CTAS balance_sheet (annual, 2024-05-31) — Retained Earnings: 10617955000.00
CTAS cash_flow (annual, 2024-05-31) — Sale Of PPE: 0.00
CTAS income_statement (annual, 2024-05-31) — Selling General And Administration: 2617783000.00
CTAS balance_sheet (annual, 2024-05-31) — Share Issued: 773097184.00
CTAS cash_flow (annual, 2024-05-31) — Stock Based Compensation: 116986000.00
CTAS balance_sheet (annual, 2024-05-31) — Stockholders Equity: 4316372000.00
CTAS balance_sheet (annual, 2024-05-31) — Tangible Book Value: 782046000.00
CTAS income_statement (annual, 2024-05-31) — Tax Effect Of Unusual Items: 0.00
CTAS income_statement (annual, 2024-05-31) — Tax Provision: 402043000.00
CTAS income_statement (annual, 2024-05-31) — Tax Rate For Calcs: 0.20
CTAS balance_sheet (annual, 2024-05-31) — Total Assets: 9168817000.00
CTAS balance_sheet (annual, 2024-05-31) — Total Capitalization: 6342306000.00
CTAS balance_sheet (annual, 2024-05-31) — Total Debt: 2668080000.00
CTAS balance_sheet (annual, 2024-05-31) — Total Equity Gross Minority Interest: 4316372000.00
CTAS income_statement (annual, 2024-05-31) — Total Expenses: 7527982000.00
CTAS balance_sheet (annual, 2024-05-31) — Total Liabilities Net Minority Interest: 4852445000.00
CTAS balance_sheet (annual, 2024-05-31) — Total Non Current Assets: 5983610000.00
CTAS balance_sheet (annual, 2024-05-31) — Total Non Current Liabilities Net Minority Interest: 3023926000.00
CTAS income_statement (annual, 2024-05-31) — Total Operating Income As Reported: 2068633000.00
CTAS balance_sheet (annual, 2024-05-31) — Total Tax Payable: 18618000.00
CTAS balance_sheet (annual, 2024-05-31) — Treasury Shares Number: 368089208.00
CTAS balance_sheet (annual, 2024-05-31) — Treasury Stock: 8698085000.00
CTAS balance_sheet (annual, 2024-05-31) — Work In Process: 48458000.00
CTAS balance_sheet (annual, 2024-05-31) — Working Capital: 1356688000.00
CTAS cash_flow (quarterly, 2024-08-31) — Change In Income Tax Payable: 65450000.00
CTAS cash_flow (quarterly, 2024-08-31) — Change In Tax Payable: 65450000.00
CTAS balance_sheet (quarterly, 2024-08-31) — Commercial Paper: 166000000.00
CTAS balance_sheet (quarterly, 2024-08-31) — Current Debt: 615702000.00
CTAS cash_flow (quarterly, 2024-08-31) — Long Term Debt Payments: 0.00
CTAS cash_flow (quarterly, 2024-08-31) — Net Long Term Debt Issuance: 0.00
CTAS balance_sheet (quarterly, 2024-08-31) — Other Current Borrowings: 449702000.00
CTAS cash_flow (quarterly, 2024-08-31) — Repayment Of Debt: 0.00
CTAS balance_sheet (quarterly, 2024-11-30) — Commercial Paper: 181000000.00
CTAS balance_sheet (quarterly, 2024-11-30) — Current Debt: 630808000.00
CTAS cash_flow (quarterly, 2024-11-30) — Issuance Of Debt: 15000000.00
CTAS cash_flow (quarterly, 2024-11-30) — Long Term Debt Payments: 0.00
CTAS cash_flow (quarterly, 2024-11-30) — Net Long Term Debt Issuance: 0.00
CTAS cash_flow (quarterly, 2024-11-30) — Net Short Term Debt Issuance: 15000000.00
CTAS balance_sheet (quarterly, 2024-11-30) — Other Current Borrowings: 449808000.00
CTAS cash_flow (quarterly, 2024-11-30) — Repayment Of Debt: 0.00
CTAS cash_flow (quarterly, 2024-11-30) — Short Term Debt Issuance: 15000000.00
CTAS balance_sheet (quarterly, 2024-11-30) — Taxes Receivable: 10920000.00
CTAS income_statement (quarterly, 2025-02-28) — +Operating Expense: 709488000.00
CTAS income_statement (quarterly, 2025-02-28) — +Total Revenue: 2609159000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Accounts Payable: 408461000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Accounts Receivable: 1397824000.00
CTAS cash_flow (quarterly, 2025-02-28) — Amortization Cash Flow: 49149000.00
CTAS cash_flow (quarterly, 2025-02-28) — Amortization Of Intangibles: 49149000.00
CTAS income_statement (quarterly, 2025-02-28) — Basic Average Shares: 403769000.00
CTAS income_statement (quarterly, 2025-02-28) — Basic EPS: 1.14
CTAS cash_flow (quarterly, 2025-02-28) — Beginning Cash Position: 122395000.00
CTAS cash_flow (quarterly, 2025-02-28) — Capital Expenditure: -99923000.00
CTAS cash_flow (quarterly, 2025-02-28) — Capital Expenditure Reported: -99923000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Capital Lease Obligations: 214450000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Capital Stock: 2525876000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Cash And Cash Equivalents: 243428000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Cash Cash Equivalents And Short Term Investments: 243428000.00
CTAS cash_flow (quarterly, 2025-02-28) — Cash Dividends Paid: -158139000.00
CTAS cash_flow (quarterly, 2025-02-28) — Cash Flow From Continuing Financing Activities: -372112000.00
CTAS cash_flow (quarterly, 2025-02-28) — Cash Flow From Continuing Investing Activities: -125369000.00
CTAS cash_flow (quarterly, 2025-02-28) — Cash Flow From Continuing Operating Activities: 620496000.00
CTAS cash_flow (quarterly, 2025-02-28) — Change In Account Payable: -7493000.00
CTAS cash_flow (quarterly, 2025-02-28) — Change In Accrued Expense: 122584000.00
CTAS cash_flow (quarterly, 2025-02-28) — Change In Inventory: -26804000.00
CTAS cash_flow (quarterly, 2025-02-28) — Change In Other Current Assets: -6837000.00
CTAS cash_flow (quarterly, 2025-02-28) — Change In Other Working Capital: 9974000.00
CTAS cash_flow (quarterly, 2025-02-28) — Change In Payable: -7493000.00
CTAS cash_flow (quarterly, 2025-02-28) — Change In Payables And Accrued Expense: 115091000.00
CTAS cash_flow (quarterly, 2025-02-28) — Change In Prepaid Assets: -35957000.00
CTAS cash_flow (quarterly, 2025-02-28) — Change In Receivables: -29708000.00
CTAS cash_flow (quarterly, 2025-02-28) — Change In Working Capital: 25759000.00
CTAS cash_flow (quarterly, 2025-02-28) — Changes In Account Receivables: -29708000.00
CTAS cash_flow (quarterly, 2025-02-28) — Changes In Cash: 123015000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Common Stock: 2525876000.00
CTAS cash_flow (quarterly, 2025-02-28) — Common Stock Dividend Paid: -158139000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Common Stock Equity: 4592248000.00
CTAS cash_flow (quarterly, 2025-02-28) — Common Stock Payments: -26611000.00
CTAS income_statement (quarterly, 2025-02-28) — Cost Of Revenue: 1289818000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Current Accrued Expenses: 825032000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Current Assets: 3341428000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Current Capital Lease Obligation: 48786000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Current Debt: 449915000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Current Debt And Capital Lease Obligation: 498701000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Current Liabilities: 1941146000.00
CTAS cash_flow (quarterly, 2025-02-28) — Deferred Income Tax: -11039000.00
CTAS cash_flow (quarterly, 2025-02-28) — Deferred Tax: -11039000.00
CTAS cash_flow (quarterly, 2025-02-28) — Depreciation: 76374000.00
CTAS cash_flow (quarterly, 2025-02-28) — Depreciation Amortization Depletion: 125523000.00
CTAS cash_flow (quarterly, 2025-02-28) — Depreciation And Amortization: 125523000.00
CTAS income_statement (quarterly, 2025-02-28) — Diluted Average Shares: 410307000.00
CTAS income_statement (quarterly, 2025-02-28) — Diluted EPS: 1.13
CTAS income_statement (quarterly, 2025-02-28) — Diluted NI Availto Com Stockholders: 461868000.00
CTAS income_statement (quarterly, 2025-02-28) — EBIT: 611202000.00
CTAS income_statement (quarterly, 2025-02-28) — EBITDA: 736725000.00
CTAS cash_flow (quarterly, 2025-02-28) — Effect Of Exchange Rate Changes: -1982000.00
CTAS cash_flow (quarterly, 2025-02-28) — End Cash Position: 243428000.00
CTAS cash_flow (quarterly, 2025-02-28) — Financing Cash Flow: -372112000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Finished Goods: 1455505000.00
CTAS cash_flow (quarterly, 2025-02-28) — Free Cash Flow: 520573000.00
CTAS cash_flow (quarterly, 2025-02-28) — Gain Loss On Sale Of PPE: -15046000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Gains Losses Not Affecting Retained Earnings: 57050000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Goodwill: 3353553000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Goodwill And Other Intangible Assets: 3668889000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Gross PPE: 1819813000.00
CTAS income_statement (quarterly, 2025-02-28) — Gross Profit: 1319341000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Income Tax Payable: 0.00
CTAS income_statement (quarterly, 2025-02-28) — Interest Expense: 24764000.00
CTAS income_statement (quarterly, 2025-02-28) — Interest Expense Non Operating: 24764000.00
CTAS income_statement (quarterly, 2025-02-28) — Interest Income: 1349000.00
CTAS income_statement (quarterly, 2025-02-28) — Interest Income Non Operating: 1349000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Inventory: 1520865000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Invested Capital: 7069640000.00
CTAS cash_flow (quarterly, 2025-02-28) — Investing Cash Flow: -125369000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Investments And Advances: 336892000.00
CTAS cash_flow (quarterly, 2025-02-28) — Issuance Of Debt: -181000000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Long Term Capital Lease Obligation: 165664000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Long Term Debt: 2027477000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Long Term Debt And Capital Lease Obligation: 2193141000.00
CTAS cash_flow (quarterly, 2025-02-28) — Long Term Debt Payments: 0.00
CTAS cash_flow (quarterly, 2025-02-28) — Net Business Purchase And Sale: -43924000.00
CTAS cash_flow (quarterly, 2025-02-28) — Net Common Stock Issuance: -26611000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Net Debt: 2233964000.00
CTAS income_statement (quarterly, 2025-02-28) — Net Income: 463497000.00
CTAS income_statement (quarterly, 2025-02-28) — Net Income Common Stockholders: 461868000.00
CTAS income_statement (quarterly, 2025-02-28) — Net Income Continuous Operations: 463497000.00
CTAS income_statement (quarterly, 2025-02-28) — Net Income From Continuing And Discontinued Operation: 463497000.00
CTAS income_statement (quarterly, 2025-02-28) — Net Income From Continuing Operation Net Minority Interest: 463497000.00
CTAS cash_flow (quarterly, 2025-02-28) — Net Income From Continuing Operations: 463497000.00
CTAS income_statement (quarterly, 2025-02-28) — Net Income Including Noncontrolling Interests: 463497000.00
CTAS income_statement (quarterly, 2025-02-28) — Net Interest Income: -23415000.00
CTAS cash_flow (quarterly, 2025-02-28) — Net Investment Purchase And Sale: 28000.00
CTAS cash_flow (quarterly, 2025-02-28) — Net Issuance Payments Of Debt: -181000000.00
CTAS cash_flow (quarterly, 2025-02-28) — Net Long Term Debt Issuance: 0.00
CTAS income_statement (quarterly, 2025-02-28) — Net Non Operating Interest Income Expense: -23415000.00
CTAS cash_flow (quarterly, 2025-02-28) — Net Other Financing Charges: -6486000.00
CTAS cash_flow (quarterly, 2025-02-28) — Net Other Investing Changes: 386000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Net PPE: 1819813000.00
CTAS cash_flow (quarterly, 2025-02-28) — Net PPE Purchase And Sale: 18064000.00
CTAS cash_flow (quarterly, 2025-02-28) — Net Short Term Debt Issuance: -181000000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Net Tangible Assets: 923359000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Non Current Accrued Expenses: 417785000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Non Current Deferred Assets: 270072000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Non Current Deferred Liabilities: 466816000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Non Current Deferred Taxes Liabilities: 466816000.00
CTAS income_statement (quarterly, 2025-02-28) — Normalized EBITDA: 736725000.00
CTAS income_statement (quarterly, 2025-02-28) — Normalized Income: 463497000.00
CTAS cash_flow (quarterly, 2025-02-28) — Operating Cash Flow: 620496000.00
CTAS cash_flow (quarterly, 2025-02-28) — Operating Gains Losses: -15046000.00
CTAS income_statement (quarterly, 2025-02-28) — Operating Income: 609853000.00
CTAS income_statement (quarterly, 2025-02-28) — Operating Revenue: 2021144000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Ordinary Shares Number: 403669000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Other Current Assets: 178648000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Other Current Borrowings: 449915000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Other Equity Adjustments: 57050000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Other Intangible Assets: 315336000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Other Non Current Assets: 174042000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Other Properties: 1819813000.00
CTAS income_statement (quarterly, 2025-02-28) — Otherunder Preferred Stock Dividend: 1629000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Payables: 408461000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Payables And Accrued Expenses: 1233493000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Pensionand Other Post Retirement Benefit Plans Current: 208952000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Preferred Stock: 0.00
CTAS income_statement (quarterly, 2025-02-28) — Pretax Income: 586438000.00
CTAS cash_flow (quarterly, 2025-02-28) — Proceeds From Stock Option Exercised: 124000.00
CTAS cash_flow (quarterly, 2025-02-28) — Purchase Of Business: -43924000.00
CTAS cash_flow (quarterly, 2025-02-28) — Purchase Of Investment: 28000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Raw Materials: 20223000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Receivables: 1398487000.00
CTAS income_statement (quarterly, 2025-02-28) — Reconciled Cost Of Revenue: 1289818000.00
CTAS income_statement (quarterly, 2025-02-28) — Reconciled Depreciation: 125523000.00
CTAS cash_flow (quarterly, 2025-02-28) — Repayment Of Debt: 0.00
CTAS cash_flow (quarterly, 2025-02-28) — Repurchase Of Capital Stock: -26611000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Retained Earnings: 11507826000.00
CTAS cash_flow (quarterly, 2025-02-28) — Sale Of PPE: 18064000.00
CTAS income_statement (quarterly, 2025-02-28) — Selling General And Administration: 709488000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Share Issued: 776172000.00
CTAS cash_flow (quarterly, 2025-02-28) — Short Term Debt Issuance: -181000000.00
CTAS cash_flow (quarterly, 2025-02-28) — Stock Based Compensation: 31802000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Stockholders Equity: 4592248000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Tangible Book Value: 923359000.00
CTAS income_statement (quarterly, 2025-02-28) — Tax Effect Of Unusual Items: 0.00
CTAS income_statement (quarterly, 2025-02-28) — Tax Provision: 122941000.00
CTAS income_statement (quarterly, 2025-02-28) — Tax Rate For Calcs: 0.21
CTAS balance_sheet (quarterly, 2025-02-28) — Taxes Receivable: 663000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Total Assets: 9611136000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Total Capitalization: 6619725000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Total Debt: 2691842000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Total Equity Gross Minority Interest: 4592248000.00
CTAS income_statement (quarterly, 2025-02-28) — Total Expenses: 1999306000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Total Liabilities Net Minority Interest: 5018888000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Total Non Current Assets: 6269708000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Total Non Current Liabilities Net Minority Interest: 3077742000.00
CTAS income_statement (quarterly, 2025-02-28) — Total Operating Income As Reported: 609853000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Total Tax Payable: 0.00
CTAS balance_sheet (quarterly, 2025-02-28) — Treasury Shares Number: 372503000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Treasury Stock: 9498504000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Work In Process: 45137000.00
CTAS balance_sheet (quarterly, 2025-02-28) — Working Capital: 1400282000.00
CTAS income_statement (annual, 2025-05-31) — +Operating Expense: 2814438000.00
CTAS income_statement (quarterly, 2025-05-31) — +Operating Expense: 728537000.00
CTAS income_statement (annual, 2025-05-31) — +Total Revenue: 10340181000.00
CTAS income_statement (quarterly, 2025-05-31) — +Total Revenue: 2667652000.00
CTAS balance_sheet (annual, 2025-05-31) — Accounts Payable: 485109000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Accounts Payable: 485109000.00
CTAS balance_sheet (annual, 2025-05-31) — Accounts Receivable: 1417381000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Accounts Receivable: 1417381000.00
CTAS balance_sheet (annual, 2025-05-31) — Accumulated Depreciation: -2842141000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Accumulated Depreciation: -2842141000.00
CTAS balance_sheet (annual, 2025-05-31) — Allowance For Doubtful Accounts Receivable: -26357000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Allowance For Doubtful Accounts Receivable: -26357000.00
CTAS cash_flow (annual, 2025-05-31) — Amortization Cash Flow: 190806000.00
CTAS cash_flow (quarterly, 2025-05-31) — Amortization Cash Flow: 44226000.00
CTAS cash_flow (annual, 2025-05-31) — Amortization Of Intangibles: 190806000.00
CTAS cash_flow (quarterly, 2025-05-31) — Amortization Of Intangibles: 44226000.00
CTAS income_statement (annual, 2025-05-31) — Basic Average Shares: 403530000.00
CTAS income_statement (quarterly, 2025-05-31) — Basic Average Shares: 403412000.00
CTAS income_statement (annual, 2025-05-31) — Basic EPS: 4.48
CTAS income_statement (quarterly, 2025-05-31) — Basic EPS: 1.11
CTAS cash_flow (annual, 2025-05-31) — Beginning Cash Position: 342015000.00
CTAS cash_flow (quarterly, 2025-05-31) — Beginning Cash Position: 243428000.00
CTAS balance_sheet (annual, 2025-05-31) — Buildings And Improvements: 769119000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Buildings And Improvements: 769119000.00
CTAS cash_flow (annual, 2025-05-31) — Capital Expenditure: -408884000.00
CTAS cash_flow (quarterly, 2025-05-31) — Capital Expenditure: -114624000.00
CTAS cash_flow (annual, 2025-05-31) — Capital Expenditure Reported: -408884000.00
CTAS cash_flow (quarterly, 2025-05-31) — Capital Expenditure Reported: -114624000.00
CTAS balance_sheet (annual, 2025-05-31) — Capital Lease Obligations: 229482000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Capital Lease Obligations: 229482000.00
CTAS balance_sheet (annual, 2025-05-31) — Capital Stock: 2593479000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Capital Stock: 2593479000.00
CTAS balance_sheet (annual, 2025-05-31) — Cash And Cash Equivalents: 263973000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Cash And Cash Equivalents: 263973000.00
CTAS balance_sheet (annual, 2025-05-31) — Cash Cash Equivalents And Short Term Investments: 263973000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Cash Cash Equivalents And Short Term Investments: 263973000.00
CTAS cash_flow (annual, 2025-05-31) — Cash Dividends Paid: -611627000.00
CTAS cash_flow (quarterly, 2025-05-31) — Cash Dividends Paid: -157924000.00
CTAS cash_flow (annual, 2025-05-31) — Cash Flow From Continuing Financing Activities: -1619011000.00
CTAS cash_flow (quarterly, 2025-05-31) — Cash Flow From Continuing Financing Activities: -468430000.00
CTAS cash_flow (annual, 2025-05-31) — Cash Flow From Continuing Investing Activities: -623638000.00
CTAS cash_flow (quarterly, 2025-05-31) — Cash Flow From Continuing Investing Activities: -149266000.00
CTAS cash_flow (annual, 2025-05-31) — Cash Flow From Continuing Operating Activities: 2165905000.00
CTAS cash_flow (quarterly, 2025-05-31) — Cash Flow From Continuing Operating Activities: 635749000.00
CTAS cash_flow (annual, 2025-05-31) — Change In Account Payable: 143973000.00
CTAS cash_flow (quarterly, 2025-05-31) — Change In Account Payable: 71174000.00
CTAS cash_flow (annual, 2025-05-31) — Change In Accrued Expense: 110166000.00
CTAS cash_flow (quarterly, 2025-05-31) — Change In Accrued Expense: 67111000.00
CTAS cash_flow (annual, 2025-05-31) — Change In Income Tax Payable: -15305000.00
CTAS cash_flow (annual, 2025-05-31) — Change In Inventory: -33947000.00
CTAS cash_flow (quarterly, 2025-05-31) — Change In Inventory: -25894000.00
CTAS cash_flow (annual, 2025-05-31) — Change In Other Current Assets: -93646000.00
CTAS cash_flow (quarterly, 2025-05-31) — Change In Other Current Assets: -33144000.00
CTAS cash_flow (annual, 2025-05-31) — Change In Payable: 128668000.00
CTAS cash_flow (quarterly, 2025-05-31) — Change In Payable: 55869000.00
CTAS cash_flow (annual, 2025-05-31) — Change In Payables And Accrued Expense: 238834000.00
CTAS cash_flow (quarterly, 2025-05-31) — Change In Payables And Accrued Expense: 122980000.00
CTAS cash_flow (annual, 2025-05-31) — Change In Prepaid Assets: -180840000.00
CTAS cash_flow (quarterly, 2025-05-31) — Change In Prepaid Assets: -34778000.00
CTAS cash_flow (annual, 2025-05-31) — Change In Receivables: -174141000.00
CTAS cash_flow (quarterly, 2025-05-31) — Change In Receivables: -15380000.00
CTAS cash_flow (annual, 2025-05-31) — Change In Tax Payable: -15305000.00
CTAS cash_flow (annual, 2025-05-31) — Change In Working Capital: -243740000.00
CTAS cash_flow (quarterly, 2025-05-31) — Change In Working Capital: 33382000.00
CTAS cash_flow (annual, 2025-05-31) — Changes In Account Receivables: -174141000.00
CTAS cash_flow (quarterly, 2025-05-31) — Changes In Account Receivables: -15380000.00
CTAS cash_flow (annual, 2025-05-31) — Changes In Cash: -76744000.00
CTAS cash_flow (quarterly, 2025-05-31) — Changes In Cash: 18053000.00
CTAS balance_sheet (annual, 2025-05-31) — Common Stock: 2593479000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Common Stock: 2593479000.00
CTAS cash_flow (annual, 2025-05-31) — Common Stock Dividend Paid: -611627000.00
CTAS cash_flow (quarterly, 2025-05-31) — Common Stock Dividend Paid: -157924000.00
CTAS balance_sheet (annual, 2025-05-31) — Common Stock Equity: 4684481000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Common Stock Equity: 4684481000.00
CTAS cash_flow (annual, 2025-05-31) — Common Stock Payments: -934800000.00
CTAS cash_flow (quarterly, 2025-05-31) — Common Stock Payments: -256671000.00
CTAS balance_sheet (annual, 2025-05-31) — Construction In Progress: 202034000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Construction In Progress: 202034000.00
CTAS income_statement (annual, 2025-05-31) — Cost Of Revenue: 5166017000.00
CTAS income_statement (quarterly, 2025-05-31) — Cost Of Revenue: 1341663000.00
CTAS balance_sheet (annual, 2025-05-31) — Current Accrued Expenses: 244401000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Current Accrued Expenses: 244401000.00
CTAS balance_sheet (annual, 2025-05-31) — Current Assets: 3436169000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Current Assets: 3436169000.00
CTAS balance_sheet (annual, 2025-05-31) — Current Capital Lease Obligation: 50744000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Current Capital Lease Obligation: 50744000.00
CTAS balance_sheet (annual, 2025-05-31) — Current Debt And Capital Lease Obligation: 50744000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Current Debt And Capital Lease Obligation: 50744000.00
CTAS balance_sheet (annual, 2025-05-31) — Current Liabilities: 1644502000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Current Liabilities: 1644502000.00
CTAS balance_sheet (annual, 2025-05-31) — Current Provisions: 263559000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Current Provisions: 263559000.00
CTAS cash_flow (annual, 2025-05-31) — Deferred Income Tax: -5807000.00
CTAS cash_flow (quarterly, 2025-05-31) — Deferred Income Tax: 1479000.00
CTAS cash_flow (annual, 2025-05-31) — Deferred Tax: -5807000.00
CTAS cash_flow (quarterly, 2025-05-31) — Deferred Tax: 1479000.00
CTAS cash_flow (annual, 2025-05-31) — Depreciation: 303377000.00
CTAS cash_flow (quarterly, 2025-05-31) — Depreciation: 77663000.00
CTAS cash_flow (annual, 2025-05-31) — Depreciation Amortization Depletion: 494183000.00
CTAS cash_flow (quarterly, 2025-05-31) — Depreciation Amortization Depletion: 121889000.00
CTAS cash_flow (annual, 2025-05-31) — Depreciation And Amortization: 494183000.00
CTAS cash_flow (quarterly, 2025-05-31) — Depreciation And Amortization: 121889000.00
CTAS income_statement (annual, 2025-05-31) — Diluted Average Shares: 410286000.00
CTAS income_statement (quarterly, 2025-05-31) — Diluted Average Shares: 409685000.00
CTAS income_statement (annual, 2025-05-31) — Diluted EPS: 4.40
CTAS income_statement (quarterly, 2025-05-31) — Diluted EPS: 1.09
CTAS income_statement (annual, 2025-05-31) — Diluted NI Availto Com Stockholders: 1805930000.00
CTAS income_statement (quarterly, 2025-05-31) — Diluted NI Availto Com Stockholders: 446696000.00
CTAS balance_sheet (annual, 2025-05-31) — Dividends Payable: 157766000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Dividends Payable: 157766000.00
CTAS income_statement (annual, 2025-05-31) — EBIT: 2365310000.00
CTAS income_statement (quarterly, 2025-05-31) — EBIT: 599475000.00
CTAS income_statement (annual, 2025-05-31) — EBITDA: 2859493000.00
CTAS income_statement (quarterly, 2025-05-31) — EBITDA: 721364000.00
CTAS cash_flow (annual, 2025-05-31) — Effect Of Exchange Rate Changes: -1298000.00
CTAS cash_flow (quarterly, 2025-05-31) — Effect Of Exchange Rate Changes: 2492000.00
CTAS cash_flow (annual, 2025-05-31) — End Cash Position: 263973000.00
CTAS cash_flow (quarterly, 2025-05-31) — End Cash Position: 263973000.00
CTAS cash_flow (annual, 2025-05-31) — Financing Cash Flow: -1619011000.00
CTAS cash_flow (quarterly, 2025-05-31) — Financing Cash Flow: -468430000.00
CTAS balance_sheet (annual, 2025-05-31) — Finished Goods: 1520391000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Finished Goods: 1520391000.00
CTAS cash_flow (annual, 2025-05-31) — Free Cash Flow: 1757021000.00
CTAS cash_flow (quarterly, 2025-05-31) — Free Cash Flow: 521125000.00
CTAS cash_flow (annual, 2025-05-31) — Gain Loss On Sale Of PPE: -19341000.00
CTAS cash_flow (quarterly, 2025-05-31) — Gain Loss On Sale Of PPE: 0.00
CTAS balance_sheet (annual, 2025-05-31) — Gains Losses Not Affecting Retained Earnings: 84389000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Gains Losses Not Affecting Retained Earnings: 84389000.00
CTAS balance_sheet (annual, 2025-05-31) — Goodwill: 3400227000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Goodwill: 3400227000.00
CTAS balance_sheet (annual, 2025-05-31) — Goodwill And Other Intangible Assets: 3710055000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Goodwill And Other Intangible Assets: 3710055000.00
CTAS balance_sheet (annual, 2025-05-31) — Gross Accounts Receivable: 1443738000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Gross Accounts Receivable: 1443738000.00
CTAS balance_sheet (annual, 2025-05-31) — Gross PPE: 4718998000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Gross PPE: 4718998000.00
CTAS income_statement (annual, 2025-05-31) — Gross Profit: 5174164000.00
CTAS income_statement (quarterly, 2025-05-31) — Gross Profit: 1325989000.00
CTAS balance_sheet (annual, 2025-05-31) — Income Tax Payable: 4034000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Income Tax Payable: 4034000.00
CTAS income_statement (annual, 2025-05-31) — Interest Expense: 101108000.00
CTAS income_statement (quarterly, 2025-05-31) — Interest Expense: 24060000.00
CTAS income_statement (annual, 2025-05-31) — Interest Expense Non Operating: 101108000.00
CTAS income_statement (quarterly, 2025-05-31) — Interest Expense Non Operating: 24060000.00
CTAS income_statement (annual, 2025-05-31) — Interest Income: 5584000.00
CTAS income_statement (quarterly, 2025-05-31) — Interest Income: 2023000.00
CTAS income_statement (annual, 2025-05-31) — Interest Income Non Operating: 5584000.00
CTAS income_statement (quarterly, 2025-05-31) — Interest Income Non Operating: 2023000.00
CTAS balance_sheet (annual, 2025-05-31) — Interest Payable: 14583000.00
CTAS balance_sheet (quarterly, 2025-05-31) — Interest Payable: 14583000.00
CTAS balance_sheet (annual, 2025-05-31) — Inventory: 1584769000.00